-
| Industry | Medical Instruments & Supplies |
|---|---|
| Sector | Healthcare |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | BE0974358906 |
| Target Price | 15.2517 |
|---|---|
| Market Cap | 230M |
| PE Ratio | None |
| Beta | 0.65 |
| Dividend Yield | None |
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NYXH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025